Randomized trial of preoperative cimetidine in patients with colorectal carcinoma with quantitative assessment of tumor-associated lymphocytes

Cancer

Volumn 85, Issue 8, 1999, Pages 1658-1663

  Kelly, Michael D ^a   King, Julie ^a   Cherian, Maya ^b   Dwerryhouse, Simon J ^a   Finlay, Ian G ^a   Adams, Warwick J ^a   King, Denis W ^a   Lubowski, David Z ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Cimetidine; Colorectal carcinoma; Computer image analysis; Immunohistochemistry; Tumor infiltrating lymphocytes

Indexed keywords

CIMETIDINE;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; ORAL DRUG ADMINISTRATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TUMOR ASSOCIATED LEUKOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANTINEOPLASTIC AGENTS; CARCINOMA; CIMETIDINE; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HISTAMINE H2 ANTAGONISTS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOPHENOTYPING; LIFE TABLES; LYMPHOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; PREMEDICATION; PREOPERATIVE CARE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033561366     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1658::AID-CNCR3>3.0.CO;2-Q     Document Type: Article

References (14)

1. Svendsen LB, Ross C, Knigge U, Frederiksen HJ, Graversen P, Kjaergard J, et al. Cimetidine as an adjuvant treatment in colorectal cancer: a double blind, randomized pilot study. Dis Colon Rectum 1995;38:514-8.
2. Matsumoto S. Cimetidine and survival with colorectal cancer. Lancet 1995;346:115.
3. Adams W, Morris D. Short course cimetidine treatment induces a lymphocyte response to colorectal cancer which correlates with an increase in survival. Lancet 1994;344: 1768-9.
4. Adams W, Lawson J, Morris D. Cimetidine inhibits in-vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994;35:1632-6.
5. Tsunoda T, Tanimura H, Yamue H, Iwahashi M, Tani M, Tamai M, et al. In-vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients. Int J Immunopharmacol 1992;14:75-81.
6. Adams WJ, Morris DL, Ross WB, Lubowski DZ, King DW, Peters L Cimetidine preserves non-specific immune function after colonic resection for cancer. Aust N Z J Surg 1994;64:847-52.
7. Adams WJ, Morris DL. Pilot study-cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial. Cancer 1997;80:15-21.
8. Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMA, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology 1986;10:437-59.
9. Watt AG, House AK. Colonic carcinoma: a quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis. Cancer 1978;41:279-82.
10. Graham DM, Appelman HD. Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol 1990;3:332-5.
11. Harrison JC, Dean PJ, El-Zeky F, Vander-Zwaag R. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of a multivariate analysis. Hum Pathol 1995;26:31-8.
12. Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, et al. Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 1996;28:543-8.
13. Jass JR, Do K-A, Simms LA, Lino H, Wynter C, Pillay SP, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut 1998;42:673-9.
14. Uchida A. Biological significance of autologous tumor-killing activity and its induction therapy. Cancer Immunol Immunother 1993;37:75-83.